UF Unveils Gentler Treatment for Aggressive Gum Disease

New research offers a breakthrough in treating gum disease without harming the mouth's healthy microbiome.

Published on Mar. 4, 2026

Got story updates? Submit your updates here. ›

Researchers at the University of Florida College of Dentistry have discovered that the primary bacterium driving gum disease, Porphyromonas gingivalis, carries an internal "genetic brake" that controls its own aggression. By locking this brake in place, future treatments could silence the pathogen while leaving beneficial bacteria untouched, offering a gentler approach to treating gum disease.

Why it matters

Gum disease affects about 42% of people over 30 in the U.S. and is a leading cause of tooth loss, costing the country over $150 billion annually in lost productivity. Current treatments rely on deep cleaning, tissue removal, or broad-spectrum antibiotics, which can harm beneficial microbes and contribute to antibiotic resistance. The new findings point to a smarter strategy that could reduce body-wide inflammation linked to gum disease.

The details

The study, led by oral biologist Jorge Frias-Lopez, Ph.D., focused on Porphyromonas gingivalis, a "keystone pathogen" that can manipulate the entire microbial community in the mouth, turning a healthy mouth into a diseased one. The researchers found that P. gingivalis uses a specific CRISPR array, designated 30.1, to throttle its own aggression, keeping it just below the level that triggers a full-scale immune attack. By deleting this genetic brake, the team found the bacterium became hyperaggressive, producing more biofilm and proving far more lethal in tests.

  • The study was led by oral biologist Jorge Frias-Lopez, Ph.D.

The players

Jorge Frias-Lopez

An oral biologist at the University of Florida College of Dentistry who led the research on a new approach to treating gum disease.

Porphyromonas gingivalis

The primary bacterium driving gum disease, which the researchers found carries an internal "genetic brake" that controls its own aggression.

Got photos? Submit your photos here. ›

What’s next

Future therapies could employ engineered bacteriophages, or viruses that target specific bacteria, to seek out P. gingivalis and inject a CRISPR instruction that locks the genetic brake in place, restoring peace to gum tissue without disrupting the mouth's microbial balance.

The takeaway

This research offers a breakthrough in treating gum disease by targeting the key pathogen driving the infection, P. gingivalis, without harming the mouth's beneficial bacteria. By silencing the bacterium's internal "genetic brake," future treatments could reduce the body-wide inflammation linked to gum disease, addressing a major public health challenge.